Effect of Combined Estradiol and Drospirenone Treatment Versus Combined Estradiol and Medroxyprogesterone Acetate Treatment on Endothelial Function: A Crossover Study.
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2016
At a glance
- Drugs Estradiol/drospirenone (Primary) ; Estradiol/medroxyprogesterone
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- 02 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2012 Planned End Date changed from 1 Jul 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 03 Feb 2012 Planned end date changed from 1 Dec 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.